Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Novamind Inc. V.HMI


Primary Symbol: NVMDF

Healthcare Biotechnology
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine.


OTCQB:NVMDF - Post by User

Novamind Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Post by stugots6on Jun 18, 2008 10:02am
306 Views
Post# 15197818

research alert

research alert
 





NEW YORK, June 16 2008 - In a research note published last night, analysts at Matrix Research upgrade United Reef Limited (URP.V) from "hold" to "buy." target price is increased to .75cdn. Deal with URSA done, the story is progressing with work in progress.
End of story...
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities